Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morgan-Capner

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of Virological Methods|June 1, 1997
An evaluation of nine commercial EIA kits for the detection of measles specific IgGL Hesketh, A Charlett, P Farrington, et al.
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Prenatal serological diagnosis of intrauterine cytomegalovirus infectionI Lange, C H Rodeck, P Morgan-Capner, et al.
Epidemiology and Infection|July 13, 2002
The changing epidemiological pattern of hepatitis A in England and WalesM C Morris, N J Gay, L M Hesketh, et al.
Epidemiology and Infection|January 8, 2005
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adultsA J Vyse, N J Gay, L M Hesketh, et al.
Communicable Disease Report. CDR Review|April 4, 1997
Childhood infection with hepatitis A and B viruses in England and WalesL M Hesketh, J D Rowlatt, N J Gay, et al.
Journal of Medical Virology|January 1, 1987
How sensitive are the commercial assays for anti-HTLV III/LAV?L J Oldham, H J Moulsdale, P P Mortimer, et al.
Communicable Disease Report. CDR Review|November 11, 1994
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaignM Ramsay, N Gay, E Miller, et al.
Communicable Disease Report. CDR Review|February 7, 1997
The epidemiology of measles in England and Wales since the 1994 vaccination campaignN Gay, M Ramsay, B Cohen, et al.
Communicable Disease Report. CDR Review|February 7, 1997
Mumps surveillance in England and Wales supports introduction of two dose vaccination scheduleN Gay, E Miller, L Hesketh, et al.
Journal of Virological Methods|September 1, 1992
Persistence of specific IgM and low avidity specific IgG1 following primary rubellaH I Thomas, P Morgan-Capner, G Enders, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of Virological Methods|June 1, 1997
An evaluation of nine commercial EIA kits for the detection of measles specific IgGL Hesketh, A Charlett, P Farrington, et al.
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Prenatal serological diagnosis of intrauterine cytomegalovirus infectionI Lange, C H Rodeck, P Morgan-Capner, et al.
Epidemiology and Infection|July 13, 2002
The changing epidemiological pattern of hepatitis A in England and WalesM C Morris, N J Gay, L M Hesketh, et al.
Epidemiology and Infection|January 8, 2005
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adultsA J Vyse, N J Gay, L M Hesketh, et al.
Communicable Disease Report. CDR Review|April 4, 1997
Childhood infection with hepatitis A and B viruses in England and WalesL M Hesketh, J D Rowlatt, N J Gay, et al.
Journal of Medical Virology|January 1, 1987
How sensitive are the commercial assays for anti-HTLV III/LAV?L J Oldham, H J Moulsdale, P P Mortimer, et al.
Communicable Disease Report. CDR Review|November 11, 1994
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaignM Ramsay, N Gay, E Miller, et al.
Communicable Disease Report. CDR Review|February 7, 1997
The epidemiology of measles in England and Wales since the 1994 vaccination campaignN Gay, M Ramsay, B Cohen, et al.
Communicable Disease Report. CDR Review|February 7, 1997
Mumps surveillance in England and Wales supports introduction of two dose vaccination scheduleN Gay, E Miller, L Hesketh, et al.
Journal of Virological Methods|September 1, 1992
Persistence of specific IgM and low avidity specific IgG1 following primary rubellaH I Thomas, P Morgan-Capner, G Enders, et al.
Pageof 13